The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Watching it now, after my kids recommend it and saw it mentioned on here. Apparently some of the figures are a open to debate but even so it’s a shocking eye opener. Well done to Netflix for commissioning this important film.
Parkdog, this has been a top performer for me, not long ago this was fixed at 6-7p for months. I’m noticing that my best investments are in ‘singular companies’. With no one else offering an opportunity to participate in this sector ANIC is like a sponge soaking up investors’ cash. Unique seems to equal rewarding on AIM, while finding winners in over-represented sectors is much more challenging.
Completely agree Pracrorrim, a unique opportunity which has only been understood by relatively few UK PIs. I think most who got in early would have to acknowledge an element of luck as the original prospectus didn’t include UK processing which is now going to be the most lucrative part of the project.
Looks good and we’ve compared our calculations before with mine close but slightly lower. I’m a bit more cautious on NdPr prices and Saltend production start, my estimate is mid-2023 to allow for construction and commissioning, Longonjo similar timeframe. I still put us at £10 sometime within 2 years. I also think Paul is thinking several moves ahead and he’ll have the following few years roughly planned already.
Wilson, congratulations for getting in at 21p. For your calculations you need to factor in number of shares in issue. Mcap divided by number of shares = share price. Pensana currently has just over 200m shares so roughly £5 SP = £1bn mcap (just 1/3 of Lynas).
Certain people on here talking about discount placing ‘inevitable’ yet the market takes us to an ATH. FFS.
Anyway welcome TCCAT. It was me who said a while back that this sector at this moment is like the microchip industry in 1970s, partly because I was reading ‘Infinite Loop’ at the time (excellent book BTW). IMO your investment will flourish, just give it enough time and ignore the nonsense.
Last fundraise:
https://www.lse.co.uk/rns/ANIC/equity-fundraise-of-163100-million-xlagt0uossrey8g.html
‘166,666,667 new Ordinary Shares at a price of 6.0 pence per new Ordinary Share (the "Issue Price"), representing a nil discount to the closing mid-market price of the Ordinary Shares on 21 October 2020’
Next one might be at a discount but I’d expect it to be well under 10%
Yeah, I was possibly a bit tough on him but sooner or later most investors get burnt on AIM - I think can help to take a dispassionate view on shares. All the same I'm loaded up here and will add on dips if they come along, it's a very exciting sector.
GreenValueHunter, my thoughts for what they're worth as an investor from almost day one.
Jim Mellon is a billionaire, professional investor and entrepreneur. Through Agronomics he has provided an opportunity for small private investors such as us to invest in future food including cellular agriculture, be aware though that his primary motive will always be to increase his own wealth. He has made moves to take the company private in the past with a derisory offer to shareholders. There is also a rather ambiguous profit bonus that he receives upon certain conditions, that has the potential to slightly dampen shareholder gains. I'm not suggesting he's any worse than anyone else, but he will put his own interests ahead of yours.
Buying Agronomics shares is pretty much the only option for small investors to gain exposure to this sector. It can be described as a fund but differs in regulatory obligations to a unit or investment trust. The shares are AIM listed which means it subject to looser regulation than main market listed share. Bottom line is you not particualarly well covered if things go wrong.
When the company raise funds by issuing more capital you may or may not be invited to participate, that's entirely up to the BoD. Fund raises generally (particuallarly on AIM) are often viewed as negative by investors and some will seek to undermine a share price on that basis. I think with Agronomics all raises so far have had a positive outcome, enabling further investments. I also think that large institutional take-up is a vote of confidence and should help to protect the interests of small investors. I would welcome further dilution to increase exposure to early stage investments.
My general feeling is that whilst not being perfect this is a worthwhile long-term investment. I'm excited for the sector but looking ahead I will be happier holding individual shares in actual companies as and when they IPO, in the meantime this will do.
https://www.investorschronicle.co.uk/news/2021/03/09/commodities-funds-for-the-reflation-trade/Mention for Agronomics at the end of this IC article primarily about commodities
https://twitter.com/FundTrading/status/1368527877176766466?s=20